vitalconnect.comHealthcare / Medical DevicesFounded: 2011Funding to Date: $308.06MM
VitalConnect, founded in 2011, is a developer of wearable biosensor technology designed for wireless patient monitoring. Their technology seeks to leverage expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms. The company's products are designed for inpatient and outpatient settings, such as hospital monitoring, post-discharge care, cardiac monitoring, and pharmaceutical solutions. VitalConnect is headquartered in San Jose, California.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/27/2024 | Series G-3 | $18.34MM | $xx.xx | $450.88MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
43,532,968
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.5x
Conversion Ratio
1.0x
Dividend Rate
10.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
06/27/2024 | Series G-2 | $11.15MM | $xx.xx | $450.88MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
37,814,359
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.5x
Conversion Ratio
1.0x
Dividend Rate
10.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
06/27/2024 | Series G-1 | $33.85MM | $xx.xx | $450.88MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
80,371,136
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.5x
Conversion Ratio
1.0x
Dividend Rate
10.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
07/18/2023 | Series F-2 | $5.31MM | $xx.xx | $399.76MM | Revelatoin Partners, Pacific General Ventures, EW Healthcare Partners | |
Price per Share
$xx.xx
Shares Outstanding
14,017,588
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Revelatoin Partners, Pacific General Ventures, EW Healthcare Partners
|
||||||
07/18/2023 | Series F-1 | $29.1MM | $xx.xx | $399.76MM | Revelatoin Partners, Pacific General Ventures, EW Healthcare Partners | |
Price per Share
$xx.xx
Shares Outstanding
69,088,317
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Revelatoin Partners, Pacific General Ventures, EW Healthcare Partners
|
||||||
01/10/2022 | Series E-3 | $1.86MM | $xx.xx | $312.45MM | EW Healthcare Partners | |
Price per Share
$xx.xx
Shares Outstanding
5,497,449
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.5x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
EW Healthcare Partners
|
||||||
01/10/2022 | Series E-2 | $4.55MM | $xx.xx | $312.45MM | EW Healthcare Partners | |
Price per Share
$xx.xx
Shares Outstanding
13,438,368
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.5x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
EW Healthcare Partners
|
||||||
01/10/2022 | Series E-1 | $32.47MM | $xx.xx | $312.45MM | EW Healthcare Partners | |
Price per Share
$xx.xx
Shares Outstanding
86,316,668
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.5x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
EW Healthcare Partners
|
||||||
06/30/2021 | Series D-2 | $34.36MM | $xx.xx | $222.36MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
101,664,201
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.5x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
06/30/2021 | Series D-1B | $7.68MM | $xx.xx | $222.36MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
28,398,037
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.5x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
06/30/2021 | Series D-1A | $43.54MM | $xx.xx | $222.36MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
128,825,642
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.5x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
05/23/2017 | Series C | $38.49MM | $xx.xx | $76.52MM | MVM Life Sciences, Baxter Ventures | |
Price per Share
$xx.xx
Shares Outstanding
113,870,654
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
7.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
MVM Life Sciences, Baxter Ventures
|
||||||
06/14/2016 | Series B-1 | $23.1MM | $xx.xx | $183.06MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,619,711
Liquidation Pref Order
6
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
10.2x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
06/14/2016 | Series B | $10.74MM | $xx.xx | $183.06MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,148,000
Liquidation Pref Order
6
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
10/31/2011 | Series S-1 | $500,000 | $xx.xx | $82.91MM | Michael Kantor | |
Price per Share
$xx.xx
Shares Outstanding
1,000,000
Liquidation Pref Order
8
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Michael Kantor
|
||||||
10/31/2011 | Series A-1 | $8.71MM | $xx.xx | $82.91MM | Michael Kantor | |
Price per Share
$xx.xx
Shares Outstanding
2,903,872
Liquidation Pref Order
7
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
6.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Michael Kantor
|
||||||
10/31/2011 | Series A | $3.29MM | $xx.xx | $82.91MM | Michael Kantor | |
Price per Share
$xx.xx
Shares Outstanding
1,096,128
Liquidation Pref Order
7
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Michael Kantor
|
||||||
01/11/2011 | FF | $1.02MM | $xx.xx | $2.55MM | Founders | |
Price per Share
$xx.xx
Shares Outstanding
10,200,000
Liquidation Pref Order
9
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Founders
|